In vivo effects of a human thyroid-stimulating monoclonal autoantibody (M22) and a human thyroid-blocking autoantibody (K1-70)

Autoimmunity Highlights

Volumn 3, Issue 1, 2012, Pages 19-25

  Furmaniak, Jadwiga ^a   Sanders, Jane ^a   Young, Stuart ^a   Kabelis, Katarzyna ^a   Sanders, Paul ^a   Evans, Michele ^a   Clark, Jill ^a   Wilmot, Jane ^a   Smith, Bernard Rees ^a  

^a RSR LTD   (United Kingdom)

Author keywords

Autoimmunity; Graves' disease; Thyroid; Thyroid blocking antibodies; Thyroid stimulating antibodies; TSH receptor

Indexed keywords

MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY K1 70; MONOCLONAL ANTIBODY M22; THYROTROPIN; THYROXINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHO CELL; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG POTENCY; FEMALE; IN VIVO STUDY; LOW DRUG DOSE; MONOTHERAPY; NONHUMAN; PRIORITY JOURNAL; RAT; THYROID DISEASE; THYROID FOLLICULAR CELL HYPERTROPHY;

EID: 84863409896     PISSN: 20380305     EISSN: 20383274     Source Type: Journal    
DOI: 10.1007/s13317-011-0025-9     Document Type: Article

References (22)

1. Rees Smith B, McLachlan SM, Furmaniak J (1988) Autoantibodies to the thyrotropin receptor. Endocr Rev 9: 106-121. doi: 10. 1210/edrv-9-1-106.
2. Rapoport B, Chazenbalk GD, Jaume JC, McLachlan SM (1998) The thyrotropin (TSH) receptor: interaction with TSH and autoantibodies. Endocr Rev 19: 673-716. doi: 10. 1210/er. 19. 6. 673.
3. McKenzie JM, Zakarija M (1992) Fetal and neonatal hyperthyroidism and hypothyroidism due to maternal TSH receptor antibodies. Thyroid 2: 155-159. doi: 10. 1089/thy. 1992. 2. 155.
4. Sanders J, Oda Y, Roberts SA, Maruyama M, Furmaniak J, Rees Smith B (1997) Understanding the thyrotropin receptor function-structure relationship. Baillieres Clin Endocrinol Metab 11: 451-479. doi: 10. 1016/S0950-351X(97)80693-3.
5. Rees Smith B, Sanders J, Furmaniak J (2007) TSH receptor antibodies. Thyroid 17: 923-938. doi: 10. 1089/thy. 2007. 0239.
6. Sanders J, Evans M, Premawardhana LDKE, Depraetere H, Jeffreys J, Richards T, Furmaniak J, Rees Smith B (2003) Human monoclonal thyroid stimulating autoantibody. Lancet 362: 126-128. doi: 10. 1016/S0140-6736(03)13866-4.
7. Sanders J, Jeffreys J, Depraetere H, Evans M, Richards T, Kiddie A, Brereton K, Premawardhana LD, Chirgadze DY, Núñez Miguel R, Blundell TL, Furmaniak J, Rees Smith B (2004) Characteristics of a human monoclonal autoantibody to the thyrotropin receptor: sequence structure and function. Thyroid 14: 560-570. doi: 10. 1089/1050725041692918.
8. Sanders J, Evans M, Betterle C, Sanders P, Bhardwaja A, Young S, Roberts E, Wilmot J, Richards T, Kiddie A, Small K, Platt H, Summerhayes S, Harris R, Reeve M, Coco G, Zanchetta R, Chen S, Furmaniak J, Rees Smith B (2008) A human monoclonal autoantibody to the thyrotropin receptor with thyroid-stimulating blocking activity. Thyroid 18: 735-746. doi: 10. 1089/thy. 2007. 0327.
9. Rees Smith B, Sanders J, Evans M, Tagami T, Furmaniak J (2009) TSH receptor-autoantibody interactions. Horm Metab Res 41: 448-455. doi: 10. 1055/s-0029-1220913.
10. Evans M, Sanders J, Tagami T, Sanders P, Young S, Roberts E, Wilmot J, Hu X, Kabelis K, Clark J, Holl S, Richards T, Collyer A, Furmaniak J, Rees Smith B (2010) Monoclonal autoantibodies to the TSH receptor, one with stimulating activity and one with blocking activity, obtained from the same blood sample. Clin Endocrinol 73: 404-412. doi: 10. 1111/j. 1365-2265. 2010. 03831. x.
11. Sanders J, Chirgadze DY, Sanders P, Baker S, Sullivan A, Bhardwaja A, Bolton J, Reeve M, Nakatake N, Evans M, Richards T, Powell M, Núñez Miguel R, Blundell TL, Furmaniak J, Rees Smith B (2007) Crystal structure of the TSH receptor in complex with a thyroid-stimulating autoantibody. Thyroid 17: 395-410. doi: 10. 1089/thy. 2007. 0034.
12. Sanders P, Young S, Sanders J, Kabelis K, Baker S, Sullivan A, Evans M, Clark J, Wilmot J, Hu X, Roberts E, Powell M, Núñez Miguel R, Furmaniak J, Rees Smith B (2011) Crystal structure of the TSH receptor bound to a blocking type TSHR autoantibody. J Mol Endocrinol 46: 81-99. doi: 10. 1530/JME-10-0127.
13. Núñez Miguel R, Sanders J, Chirgadze DY, Furmaniak J, Rees Smith B (2009) Thyroid stimulating autoantibody M22 mimics TSH binding to the TSH receptor leucine rich domain: a comparative structural study of protein-protein interactions. J Mol Endocrinol 42: 381-395. doi: 10. 1677/JME-08-0152.
14. Pacini F, Ladenson PW, Schlumberger M, Driedger A, Luster M, Kloos RT, Sherman S, Haugen B, Corone C, Molinaro E, Elisei R, Ceccarelli C, Pinchera A, Wahl RL, Leboulleux S, Ricard M, Yoo J, Busaidy NL, Delpassand E, Hanscheid H, Felbinger R, Lassmann M, Reiners C (2006) Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin in differentiated thyroid carcinoma: results of an international, randomized, controlled study. J Clin Endocrinol Metab 91: 926-932. doi: 10. 1210/jc. 2005-1651.
15. Schroeder PR, Haugen BR, Pacini F, Reiners C, Schlumberger M, Sherman SI, Cooper DS, Schuff KG, Braverman LE, Skarulis MC, Davies TF, Mazzaferri EL, Daniels GH, Ross DS, Luster M, Samuels MH, Weintraub BD, Ridgway EC, Ladenson PW (2006) A comparison of short-term changes in health-related quality of life in thyroid carcinoma patients undergoing diagnostic evaluation with recombinant human thyrotropin compared with thyroid hormone withdrawal. J Clin Endocrinol Metab 91: 878-884. doi: 10. 1210/jc. 2005-2064.
16. Horimoto M, Petersen VB, Pegg CAS, Fukuma N, Wabayashi N, Kiso Y, Furmaniak J, Rees Smith B (1992) Production and characterization of a human monoclonal thyroid peroxidase autoantibody. Autoimmunity 14: 1-7.
17. Sanders J, Bolton J, Sanders P, Jeffreys J, Nakatake N, Richards T, Evans M, Kiddie A, Summerhayes S, Roberts E, Núñez Miguel R, Furmaniak J, Rees Smith B (2006) Effects of TSH receptor mutations on binding and biological activity of monoclonal antibodies and TSH. Thyroid 16: 1195-1206. doi: 10. 1089/thy. 2006. 16. 1195.
18. Rees Smith B, Bolton J, Young S, Collyer A, Weeden A, Bradbury J, Weightman D, Perros P, Sanders J, Furmaniak J (2004) A new assay for thyrotropin receptor autoantibodies. Thyroid 14: 830-835. doi: 10. 1089/thy. 2004. 14. 830.
19. Nakatake N, Sanders J, Richards T, Burne P, Barrett C, Dal Pra C, Presotto F, Betterle C, Furmaniak J, Rees Smith B (2006) Estimation of serum TSH receptor autoantibody concentration and affinity. Thyroid 16: 1077-1084. doi: 10. 1089/thy. 2006. 16. 1077.
20. Costagliola S, Bonomi M, Morgenthaler NG, van Durme J, Panneels V, Refetoff S, Vassart G (2004) Delineation of the discontinuous-conformational epitope of a monoclonal antibody displaying full in vitro and in vivo thyrotropin activity. Mol Endocrinol 18: 3020-3034. doi: 10. 1210/me. 2004-0231.
21. Gilbert J, Gianoukakis A, Salehi S, Moorhead J, Rao P, Kahn MZ, McGregor A, Smith T, Banga JP (2006) Monoclonal pathogenic antibodies to the thyroid stimulating hormone receptor in Graves' disease with potent thyroid-stimulating activity but differential blocking activity activate multiple signalling pathways. J Immunol 176: 5084-5092.
22. Ando T, Latif R, Davies TF (2004) Concentration-dependent regulation of thyrotropin receptor function by thyroid-stimulating antibody. J Clin Invest 113: 1589-1595. doi: 10. 1172/JCI200421334.